Cassava Sciences Inc (SAVA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 7.21 | 2.55 | 1.16 | 0.91 | 1.01 | 1.18 | |||
| Changes by years, y/y, % | -51% | -65% | -55% | -21% | +11% | -41.5% | |||
Cassava Sciences Inc. Debt/EBITDA
Cassava Sciences Inc. Debt/EBITDA, changes, %
Cassava Sciences Inc (SAVA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.84 | 1.31 | 1.63 | 1.01 | 1.18 | 1.18 | ||
| Changes by years, y/y, % | -31% | -12% | +57% | +10% | +40% | |||
| Changes by quarters, q/q, % | -8% | +55% | +25% | -38% | +17% | |||